GeneOne Life Science Inc Cash Flow Reinvestment Rate

Latest as of December 2021: 32.88x

GeneOne Life Science Inc cash flow reinvestment rate. GeneOne Life Science Inc (011000) has a Cash Flow Reinvestment Rate of 32.88x as of December 2021, reinvesting ₩120.54 Billion (capex ₩35.40 Billion plus investments ₩-85.14 Billion) from operating cash flow of ₩3.67 Billion. Explore 011000 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

32.88x

(Capex + Investments) / Operating CF

Total Reinvested

₩120.54 Billion

Capex + Investments

Operating Cash Flow

₩3.67 Billion

KRW

Capital Expenditures

₩35.40 Billion

KRW

Cash Flow Reinvestment Rate of GeneOne Life Science Inc (2015–2015)

Cash flow reinvestment rate of GeneOne Life Science Inc from 2015 to 2015. Historical reinvestment intensity for GeneOne Life Science Inc across 1 annual periods. Explore reinvestment intensity of GeneOne Life Science Inc to see what proportion of operating cash flow is directed to capital expenditures.

GeneOne Life Science Inc Cash Flow Reinvestment Rate by Year (2015–2015)

GeneOne Life Science Inc cash flow reinvestment rate by year from 2015 to 2015. Year-by-year capital reinvestment analysis for GeneOne Life Science Inc. For the full cash flow conversion analysis, see GeneOne Life Science Inc cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2015	3.34x	₩2.60 Billion	₩778.50 Million	₩2.04 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow